{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T07:19:16Z","timestamp":1773299956581,"version":"3.50.1"},"reference-count":105,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.pharmthera.2008.02.001","type":"journal-article","created":{"date-parts":[[2008,2,20]],"date-time":"2008-02-20T12:38:45Z","timestamp":1203511125000},"page":"138-151","source":"Crossref","is-referenced-by-count":37,"title":["Pharmacological approach to the treatment of long and short QT syndromes"],"prefix":"10.1016","volume":"118","author":[{"given":"Chinmay","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Antzelevitch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2008.02.001_bib1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0092-8674(00)80728-X","article-title":"MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia","volume":"97","author":"Abbott","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib2","doi-asserted-by":"crossref","first-page":"413","DOI":"10.4065\/77.5.413","article-title":"Epinephrine-induced QT interval prolongation: a gene-specific paradoxical response in congenital long QT syndrome","volume":"77","author":"Ackerman","year":"2002","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib3","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.4065\/74.11.1088","article-title":"Swimming, a gene-specific arrhythmogenic trigger for inherited long QT syndrome","volume":"74","author":"Ackerman","year":"1999","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib4","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jacc.2004.09.069","article-title":"Cellular and ionic mechanism for drug-induced long QT syndrome and effectiveness of verapamil","volume":"45","author":"Aiba","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib5","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1651-2227.1971.tb06990.x","article-title":"Intermittent muscular weakness, extrasystoles, and multiple developmental anomalies. A new syndrome?","volume":"60","author":"Andersen","year":"1971","journal-title":"Acta Paediatr Scand"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib6","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/CIRCULATIONAHA.105.570200","article-title":"Most LQT2 mutations reduce Kv11.1 (hERG) current by a class 2 (trafficking-deficient) mechanism","volume":"113","author":"Anderson","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib7","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1161\/CIRCULATIONAHA.106.668392","article-title":"Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death","volume":"115","author":"Antzelevitch","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib8","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/j.1540-8167.1999.tb00287.x","article-title":"The M cell: its contribution to the ECG and to normal and abnormal electrical function of the heart","volume":"10","author":"Antzelevitch","year":"1999","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib9","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1540-8167.1999.tb00667.x","article-title":"The controversial M cell","volume":"10","author":"Anyukhovsky","year":"1999","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib10","series-title":"Cardiac Repolarization. Bridging Basic and Clinical Science","first-page":"127","article-title":"Electrical and structural remodeling of the ventricular myocardium in disease","author":"Armoundas","year":"2003"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib11","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/384078a0","article-title":"KvLQT1 and IsK (minK) proteins associate to form the IKs cardiac potassium current","volume":"384","author":"Barhanin","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib12","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1161\/01.CIR.0000130409.72142.FE","article-title":"Mutation in the KCNQ1 gene leading to the short QT-interval syndrome","volume":"109","author":"Bellocq","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib13","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1161\/01.CIR.101.14.1698","article-title":"Effects of flecainide in patients with new SCN5A mutation: mutation-specific therapy for long-QT syndrome?","volume":"101","author":"Benhorin","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib14","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1542-474X.2005.00064.x","article-title":"Short QT syndrome","volume":"10","author":"Bjerregaard","year":"2005","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib15","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/ncpcardio0097","article-title":"Short QT syndrome: mechanisms, diagnosis and treatment","volume":"2","author":"Bjerregaard","year":"2005","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib16","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1161\/01.CIR.0000109482.92774.3A","article-title":"Sudden death associated with short-QT syndrome linked to mutations in HERG","volume":"109","author":"Brugada","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib17","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/pd.475","article-title":"Prenatal diagnosis and treatment of fetal long QT syndrome: a case report","volume":"22","author":"Chang","year":"2002","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib18","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1161\/01.CIR.94.5.1018","article-title":"Genetically defined therapy of inherited long-QT syndrome. Correction of abnormal repolarization by potassium","volume":"94","author":"Compton","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib19","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.cardiores.2005.02.018","article-title":"Modulation of IKr inactivation by mutation N588K in KCNH2: a link to arrhythmogenesis in short QT syndrome","volume":"67","author":"Cordeiro","year":"2005","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib20","doi-asserted-by":"crossref","first-page":"35749","DOI":"10.1074\/jbc.M305787200","article-title":"Thapsigargin selectively rescues the trafficking defective LQT2 channels G601S and F805C","volume":"278","author":"Delisle","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib21","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/0735-1097(92)90180-U","article-title":"Combined use of beta-adrenergic blocking agents and long-term cardiac pacing for patients with the long QT syndrome","volume":"20","author":"Eldar","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib22","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/j.jacc.2003.07.006","article-title":"A new oral therapy for long QT syndrome: long-term oral potassium improves repolarization in patients with HERG mutations","volume":"42","author":"Etheridge","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib23","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.jacc.2004.02.034","article-title":"Short QT syndrome: pharmacological treatment","volume":"43","author":"Gaita","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib24","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1161\/01.CIR.0000085071.28695.C4","article-title":"Short QT syndrome: a familial cause of sudden death","volume":"108","author":"Gaita","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib25","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehl185","article-title":"Short QT syndrome: clinical findings and diagnostic-therapeutic implications","author":"Giustetto","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib26","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.cardiores.2004.02.011","article-title":"New KCNQ1 mutations leading to haploinsufficiency in a general population; defective trafficking of a KvLQT1 mutant","volume":"63","author":"Gouas","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib27","series-title":"Cardiac Repolarization. Bridging Basic and Clinical Sciences","first-page":"497","article-title":"Short QT interval: ECG phenomenon and clinical syndrome","author":"Gussak","year":"2003"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib28","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jelectrocard.2005.06.012","article-title":"Short QT syndrome-5\u00a0years of progress","volume":"38","author":"Gussak","year":"2005","journal-title":"J Electrocardiol"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib29","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000047299","article-title":"Idiopathic short QT interval: a new clinical syndrome?","volume":"94","author":"Gussak","year":"2000","journal-title":"Cardiology"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib30","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0735-1097(96)00313-0","article-title":"Frequency-dependent electrophysiologic properties of ventricular repolarization in patients with congenital long QT syndrome","volume":"28","author":"Hirao","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib31","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1001\/jama.296.10.1249","article-title":"Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome","volume":"296","author":"Hobbs","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib32","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1046\/j.1540-8167.2005.40621.x","article-title":"Short QT syndrome and atrial fibrillation caused by mutation in KCNH2","volume":"16","author":"Hong","year":"2005","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib33","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.hrthm.2006.04.024","article-title":"Verapamil decreases ventricular tachyarrhythmias in a patient with Timothy syndrome (LQT8)","volume":"3","author":"Jacobs","year":"2006","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib34","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0002-8703(57)90079-0","article-title":"Congenital deaf-mutism, functional heart disease with prolongation of the QT interval and sudden death","volume":"54","author":"Jervell","year":"1957","journal-title":"Am Heart J"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib35","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1124\/mol.104.006577","article-title":"Discovery of a small molecule activator of the human ether-a-go-go-related gene (HERG) cardiac K+ channel","volume":"67","author":"Kang","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib36","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.hrthm.2004.01.006","article-title":"Identification of a common genetic substrate underlying postpartum cardiac events in congenital long QT syndrome","volume":"1","author":"Khositseth","year":"2004","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib37","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.resuscitation.2006.03.011","article-title":"Short QT syndrome: a case report and review of literature","volume":"71","author":"Lu","year":"2006","journal-title":"Resuscitation"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib38","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.yjmcc.2006.05.021","article-title":"Disopyramide is an effective inhibitor of mutant HERG K+ channels involved in variant 1 short QT syndrome","volume":"41","author":"McPate","year":"2006","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib39","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1161\/CIRCULATIONAHA.106.659086","article-title":"SCN4B-encoded sodium channel beta4 subunit in congenital long-QT syndrome","volume":"116","author":"Medeiros-Domingo","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib40","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1161\/01.CIR.0000130666.81539.9E","article-title":"Recurrent third-trimester fetal loss and maternal mosaicism for long-QT syndrome","volume":"109","author":"Miller","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib41","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/nature01335","article-title":"Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death","volume":"421","author":"Mohler","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib42","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S0002-9149(99)00458-0","article-title":"Comparison of clinical and genetic variables of cardiac events associated with loud noise versus swimming among subjects with the long QT syndrome","volume":"84","author":"Moss","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib43","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1161\/01.CIR.71.1.17","article-title":"The long QT syndrome:a prospective international study","volume":"71","author":"Moss","year":"1985","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib44","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1161\/01.CIR.92.10.2929","article-title":"ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome","volume":"92","author":"Moss","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib45","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1161\/01.CIR.101.6.616","article-title":"Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome","volume":"101","author":"Moss","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib46","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1053\/euhj.2001.3079","article-title":"Gene-specific response of dynamic ventricular repolarization to sympathetic stimulation in LQT1, LQT2 and LQT3 forms of congenital long QT syndrome","volume":"23","author":"Noda","year":"2002","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib47","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0092-8674(01)00342-7","article-title":"Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome","volume":"105","author":"Plaster","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib48","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1540-8167.2005.51212.x","article-title":"From genes to cell therapy: molecular medicine meets clinical EP","volume":"16","author":"Priori","year":"2005","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib49","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1161\/01.CIR.102.9.945","article-title":"The elusive link between LQT3 and Brugada syndrome: the role of flecainide challenge","volume":"102","author":"Priori","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib50","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1001\/jama.292.11.1341","article-title":"Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers","volume":"292","author":"Priori","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib51","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1161\/01.RES.0000162101.76263.8c","article-title":"A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene","volume":"96","author":"Priori","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib52","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1056\/NEJMoa022147","article-title":"Risk stratification in the long-QT syndrome","volume":"348","author":"Priori","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib53","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1111\/j.1540-8167.2007.00923.x","article-title":"Increasing gap junction coupling reduces transmural dispersion of repolarization and prevents torsade de pointes in rabbit LQT3 model","volume":"18","author":"Quan","year":"2007","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib54","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1161\/01.CIR.0000019513.50928.74","article-title":"Pharmacological rescue of human K(+) channel long-QT2 mutations: human ether-a-go-go-related gene rescue without block","volume":"105","author":"Rajamani","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib55","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1161\/01.CIR.94.8.1996","article-title":"Multiple mechanisms in the long-QT syndrome. Current knowledge, gaps, and future directions. The SADS foundation task force on LQTS","volume":"94","author":"Roden","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib56","first-page":"656","article-title":"Aritmie cardiache rare dell'eta pediatrica","volume":"45","author":"Romano","year":"1963","journal-title":"Clin Pediatr"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib57","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1540-8167.1995.tb00423.x","article-title":"The molecular basis of anisotropy: role of gap junctions","volume":"6","author":"Saffitz","year":"1995","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib58","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/384080a0","article-title":"Coassembly of KvLQT1 and minK (IsK) proteins to form cardiac IKs potassium channel","volume":"384","author":"Sanguinetti","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib59","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0092-8674(95)90340-2","article-title":"A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel","volume":"81","author":"Sanguinetti","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib60","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jacc.2006.08.057","article-title":"Long QT syndrome in adults","volume":"49","author":"Sauer","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib61","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.hrthm.2004.11.026","article-title":"Short QT syndrome: successful prevention of sudden cardiac death in an adolescent by implantable cardioverter-defibrillator treatment for primary prophylaxis","volume":"2","author":"Schimpf","year":"2005","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib62","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1540-8167.2007.00925.x","article-title":"In vivo effects of mutant HERG K+ channel inhibition by disopyramide in patients with a short QT-1 syndrome: a pilot study","volume":"18","author":"Schimpf","year":"2007","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib63","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1046\/j.1540-8167.2003.03278.x","article-title":"Congenital short QT syndrome and implantable cardioverter defibrillator treatment: inherent risk for inappropriate shock delivery","volume":"14","author":"Schimpf","year":"2003","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib64","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/0002-8703(75)90089-7","article-title":"The long QT syndrome","volume":"89","author":"Schwartz","year":"1975","journal-title":"Am Heart J"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib65","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1161\/01.CIR.0000125523.14403.1E","article-title":"Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome","author":"Schwartz","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib66","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1161\/01.CIR.92.12.3381","article-title":"Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate: implications for gene-specific therapy","volume":"92","author":"Schwartz","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib67","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1161\/01.CIR.103.1.89","article-title":"Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias","volume":"103","author":"Schwartz","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib68","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1161\/CIRCULATIONAHA.105.592899","article-title":"The Jervell and Lange-Nielsen syndrome: natural history, molecular basis, and clinical outcome","volume":"113","author":"Schwartz","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib69","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1056\/NEJM199806113382401","article-title":"Prolongation of the QT interval and the sudden infant death syndrome","volume":"338","author":"Schwartz","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib70","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1161\/01.CIR.96.6.2038","article-title":"Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade de pointes in LQT2 and LQT3 models of the long-QT syndrome","volume":"96","author":"Shimizu","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib71","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1161\/01.CIR.98.21.2314","article-title":"Cellular basis for the ECG features of the LQT1 form of the long QT syndrome: effects of b-adrenergic agonists and antagonists and sodium channel blockers on transmural dispersion of repolarization and torsade de pointes","volume":"98","author":"Shimizu","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib72","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1161\/01.CIR.99.11.1499","article-title":"Cellular and ionic basis for T-wave alternans under Long QT conditions","volume":"99","author":"Shimizu","year":"1999","journal-title":"Circulation"},{"issue":"Supplement","key":"10.1016\/j.pharmthera.2008.02.001_bib73","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0022-0736(99)90077-8","article-title":"Cellular basis for long QT, transmural dispersion of repolarization, and torsade de pointes in the long QT syndrome","volume":"32","author":"Shimizu","year":"1999","journal-title":"J Electrocardiol"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib74","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S0735-1097(99)00582-3","article-title":"Differential effects of beta-adrenergic agonists and antagonists in LQT1, LQT2 and LQT3 models of the long QT syndrome","volume":"35","author":"Shimizu","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib75","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1161\/01.CIR.102.6.706","article-title":"Effects of a K(+) channel opener to reduce transmural dispersion of repolarization and prevent torsade de pointes in LQT1, LQT2, and LQT3 models of the long-QT syndrome","volume":"102","author":"Shimizu","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib76","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1161\/01.CIR.97.16.1581","article-title":"Improvement of repolarization abnormalities by a K+ channel opener in the LQT1 form of congenital long QT syndrome","volume":"97","author":"Shimizu","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib77","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0735-1097(02)02850-4","article-title":"Epinephrine unmasks latent mutation carriers with LQT1 form of congenital long-QT syndrome","volume":"41","author":"Shimizu","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib78","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/0735-1097(95)00313-4","article-title":"Effects of verapamil and propranolol on early after depolarizations and ventricular arrhythmias induced by epinephrine in congenital long QT syndrome","volume":"26","author":"Shimizu","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib79","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/S0735-1097(02)01894-6","article-title":"Differential effects of beta-blockade on dispersion of repolarization in the absence and presence of sympathetic stimulation between the LQT1 and LQT2 forms of congenital long QT syndrome","volume":"39","author":"Shimizu","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib80","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.hrthm.2006.12.046","article-title":"Cellular basis for the electrocardiographic and arrhythmic manifestations of Timothy syndrome: effects of ranolazine","volume":"4","author":"Sicouri","year":"2007","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib81","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1161\/01.CIR.102.10.1178","article-title":"Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2","volume":"102","author":"Splawski","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib82","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cell.2004.09.011","article-title":"Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism","volume":"119","author":"Splawski","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib83","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0735-1097(99)00255-7","article-title":"Sinus node function and ventricular repolarization during exercise stress test in long QT syndrome patients with KvLQT1 and HERG potassium channel defects","volume":"34","author":"Swan","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib84","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1161\/01.CIR.0000048142.85076.A2","article-title":"Exercise stress test amplifies genotype\u2013phenotype correlation in the LQT1 and LQT2 forms of the long-QT syndrome","volume":"107","author":"Takenaka","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib85","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1161\/CIRCULATIONAHA.106.642694","article-title":"Genotype-specific onset of arrhythmias in congenital long-QT syndrome. possible therapy implications","volume":"114","author":"Tan","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib86","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0735-1097(00)01200-6","article-title":"Sympathetic stimulation produces a greater increase in both transmural and spatial dispersion of repolarization in LQT1 than LQT2 forms of congenital long QT syndrome","volume":"37","author":"Tanabe","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib87","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/ana.410350313","article-title":"Andersen's syndrome: potassium-sensitive periodic paralysis, ventricular ectopy, and dysmorphic features","volume":"35","author":"Tawil","year":"1994","journal-title":"Ann.Neurol."},{"key":"10.1016\/j.pharmthera.2008.02.001_bib88","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jacc.2006.10.010","article-title":"Postmortem long QT syndrome genetic testing for sudden unexplained death in the young","volume":"49","author":"Tester","year":"2007","journal-title":"J.Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib89","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1161\/CIRCULATIONAHA.106.635268","article-title":"Mutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome","volume":"114","author":"Vatta","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib90","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1136\/hrt.79.4.417","article-title":"Prevention of torsade de pointes in the congenital long QT syndrome: use of a pause prevention pacing algorithm","volume":"79","author":"Viskin","year":"1998","journal-title":"Heart"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib91","doi-asserted-by":"crossref","first-page":"111K","DOI":"10.1016\/S0002-9149(00)01228-5","article-title":"Rate smoothing with cardiac pacing for preventing torsade de pointes","volume":"86","author":"Viskin","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib92","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1161\/01.CIR.101.10.1192","article-title":"Cellular arrhythmogenic effects of the congenital and acquired long QT syndrome in the heterogeneous myocardium","volume":"101","author":"Viswanathan","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib93","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0092-8674(95)90359-3","article-title":"SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome","volume":"80","author":"Wang","year":"1995","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.pharmthera.2008.02.001_bib94","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0735-1097(98)00578-6","article-title":"Auditory stimuli as a trigger for arrhythmic events differentiate HERG-related (LQTS2) patients from KVLQT1-related patients (LQTS1)","volume":"33","author":"Wilde","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib95","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1046\/j.1540-8167.2005.04470.x","article-title":"Further insights into the effect of quinidine in short QT syndrome caused by a mutation in HERG","volume":"16","author":"Wolpert","year":"2005","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib96","doi-asserted-by":"crossref","first-page":"H664","DOI":"10.1152\/ajpheart.00076.2002","article-title":"Increasing I(Ks) corrects abnormal repolarization in rabbit models of acquired LQT2 and ventricular hypertrophy","volume":"283","author":"Xu","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib97","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1161\/01.CIR.98.18.1928","article-title":"Cellular basis for the normal T wave and the electrocardiographic manifestations of the long QT syndrome","volume":"98","author":"Yan","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib98","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.1540-8167.2003.02545.x","article-title":"Implantable cardioverter defibrillator in high-risk long QT syndrome patients","volume":"14","author":"Zareba","year":"2003","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib99","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1056\/NEJM199810013391404","article-title":"Influence of genotype on the clinical course of the long-QT syndrome. International long-QT syndrome registry research group","volume":"339","author":"Zareba","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib100","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1161\/01.CIR.102.23.2849","article-title":"Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes","volume":"102","author":"Zhang","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib101","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1124\/mol.105.014035","article-title":"Novel potent human ether-a-go-go-related gene (hERG) potassium channel enhancers and their in vitro antiarrhythmic activity","volume":"68","author":"Zhou","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib102","doi-asserted-by":"crossref","first-page":"21061","DOI":"10.1074\/jbc.273.33.21061","article-title":"HERG channel dysfunction in human long QT syndrome. Intracellular transport and functional defects","volume":"273","author":"Zhou","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib103","doi-asserted-by":"crossref","first-page":"31123","DOI":"10.1074\/jbc.274.44.31123","article-title":"Correction of defective protein trafficking of a mutant HERG potassium channel in human long QT syndrome. Pharmacological and temperature effects","volume":"274","author":"Zhou","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib104","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1161\/01.CIR.84.3.1414","article-title":"The long QT interval syndrome: a Rosetta stone for sympathetic related ventricular tachyarrhythmias","volume":"84","author":"Zipes","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2008.02.001_bib105","first-page":"H689","article-title":"Larger late sodium conductance in M cells contributes to electrical heterogeneity in canine ventricle","volume":"281","author":"Zygmunt","year":"2001","journal-title":"Am J Physiol"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725808000338?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725808000338?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,2]],"date-time":"2020-05-02T03:43:48Z","timestamp":1588391028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725808000338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":105,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S0163725808000338"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2008.02.001","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}